Skip to main content

Market Overview

RESHAPE LIFESCIENCES INC by ReShape Lifesciences Inc. RSLS:OTCQB OTCQB
Early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.

{{ portfolio.portfolio_name }}
You have no watchlists at this time, click "Manage watchlists" to create your first watchlist.
Manage watchlists

Sector: Health Care Industry: Health Care Equipment & Supplies

4.520 4.26 (1640.47%)

Data as of May 09, 2021

Prev. Close 0.2597
Price Open
Volume 506
Day's Range -
52 Wk Range 1.14 - 7.45
50 Day Moving Avg. 4.85
PE Ratio
Shares Outstanding 6.17M
Market Cap 27.87M

Trade RSLS stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

The Daily Biotech Pulse: Mesoblast Awaits Adcom Test, BioCryst Rallies On Insider Buying, Sorrento Hits Back At Short Seller Shanthi RexalineThu, 13 Aug 2020 08:18:20 -0400
ReShape Lifesciences Announces 1-For-120 Reverse Stock Split Effective Nov. 12 Benzinga NewsdeskMon, 11 Nov 2019 13:53:30 -0400
The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering Shanthi RexalineWed, 14 Aug 2019 07:50:27 -0400
The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout Shanthi RexalineWed, 07 Aug 2019 07:34:05 -0400
Reshape Lifesciences Q1 EPS $(0.54) Down From $(0.36) YoY, Sales $3.074M Up From $139K YoY Benzinga NewsdeskMon, 20 May 2019 16:23:11 -0400
ReShape Lifesciences FY18 Sales $2.8M Up From $2.3M YoY Benzinga NewsdeskMon, 01 Apr 2019 16:09:42 -0400
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs Shanthi RexalineSat, 30 Mar 2019 09:32:40 -0400
48 Biggest Movers From Friday Lisa LevinMon, 31 Dec 2018 06:18:32 -0400
Mid-Afternoon Market Update: Dow Rises 150 Points; Obalon Therapeutics Shares Plunge Lisa LevinFri, 28 Dec 2018 15:21:21 -0400
26 Stocks Moving In Friday's Mid-Day Session Lisa LevinFri, 28 Dec 2018 13:43:17 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Penny Stocks to Buy During the Cryptocurrency Boom? Here's 3 to Watch Pennystocks.comApr 19, 2021
ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results ACCESSWIREMar 10, 2021
Reshape Lifesciences to Report Fourth Quarter and Full Year 2020 Financial and Operational Results on Wednesday, March 10, 2021 ACCESSWIREMar 08, 2021
OBALON ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of OBLN and Encourages Investors to Contact the Firm Globe NewswireJan 22, 2021
OBALON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Obalon Therapeutics, Inc. - OBLN Business WireJan 22, 2021
SHAREHOLDER ALERT: WeissLaw LLP Investigates Obalon Therapeutics, Inc. PRNewswireJan 21, 2021
ReShape Lifesciences Inc. to Merge With Obalon Therapeutics, Inc. to Expand Weight Loss Product Offering ACCESSWIREJan 20, 2021
ReShape Lifesciences Announces Third Quarter 2020 Financial and Operational Results ACCESSWIRENov 12, 2020
ReShape Lifesciences to Report Third Quarter 2020 Financial and Operational Results on Thursday, November 12, 2020 ACCESSWIRENov 10, 2020
First Twenty-five Healthcare Professionals Enrolled in ReShapeCare™, a Reimbursable, Evidence-based Virtual Weight Management Program PRNewswireSep 15, 2020
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

OBLN Stock: 12 Things to Know About the ReShape-Obalon Merger as Shares Balloon Higher InvestorPlaceJan 20, 2021
ReShape Lifesciences' (RSLS) CEO Bart Bandy on Q3 2019 Results - Earnings Call Transcript Seeking AlphaNov 14, 2019
ReShape Lifesciences reports Q3 results Seeking AlphaNov 14, 2019
ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q2 2019 Results - Earnings Call Transcript Seeking AlphaAug 14, 2019
ReShape Lifesciences reports Q2 results Seeking AlphaAug 14, 2019
ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q1 2019 Results - Earnings Call Transcript Seeking AlphaMay 20, 2019
ReShape Lifesciences reports Q1 results Seeking AlphaMay 20, 2019
ReShape Lifesciences Inc.'s (RSLS) CEO Dan Gladney on Q4 2018 Results - Earnings Call Transcript Seeking AlphaApr 01, 2019
ReShape Lifesciences reports Q4 results Seeking AlphaApr 01, 2019
ReShape Lifesciences announces $2M convertible note financing Seeking AlphaMar 29, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Earnings View Earnings

Q1 2020	EST	Actual	Surprise
EPS:	Expected 2020-05-14
Rev:	Expected 2020-05-14

	EST	Actual	Surprise
EPS:	Expected
Rev:	Expected

Start Investing

The Best Online Stock Trading Brokers

Best Free Stock Trading Brokers

Best Forex Brokers

Best Futures Brokers

How to Invest in Real Estate

Best Day Trading Courses